How chronic are depressive and anxiety disorders? 9-year general population study using narrow and broad course outcomes.

[1]  J. Leung,et al.  Estimating the global treatment rates for depression: A systematic review and meta-analysis. , 2021, Journal of affective disorders.

[2]  R. de Graaf,et al.  Recurrence of anxiety disorders and its predictors in the general population , 2021, Psychological Medicine.

[3]  R. de Graaf,et al.  Course trajectories of anxiety disorders: Results from a 6-year follow-up in a general population study , 2021, The Australian and New Zealand journal of psychiatry.

[4]  R. de Graaf,et al.  Duration of anxiety disorder and its associated risk indicators: Results of a longitudinal study of the general population , 2020, Depression and anxiety.

[5]  B. Penninx,et al.  A clinical staging approach to improving diagnostics in anxiety disorders: Is it the way to go? , 2019, The Australian and New Zealand journal of psychiatry.

[6]  R. de Graaf,et al.  Recurrence and chronicity of major depressive disorder and their risk indicators in a population cohort , 2018, Acta psychiatrica Scandinavica.

[7]  P. de Jonge,et al.  Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review , 2018, Epidemiology and Psychiatric Sciences.

[8]  A. Beekman,et al.  Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule , 2017, BMC Medicine.

[9]  M. Olfson,et al.  A comprehensive model of predictors of persistence and recurrence in adults with major depression: Results from a national 3-year prospective study. , 2017, Journal of psychiatric research.

[10]  R. de Graaf,et al.  Duration of major and minor depressive episodes and associated risk indicators in a psychiatric epidemiological cohort study of the general population , 2017, Acta psychiatrica Scandinavica.

[11]  P. de Jonge,et al.  The ten-year course of depression in primary care and long-term effects of psychoeducation, psychiatric consultation and cognitive behavioral therapy. , 2017, Journal of affective disorders.

[12]  B. Penninx,et al.  Diagnostic instability of recurrence and the impact on recurrence rates in depressive and anxiety disorders. , 2016, Journal of affective disorders.

[13]  B. Penninx,et al.  Low stability of diagnostic classifications of anxiety disorders over time: A six-year follow-up of the NESDA study. , 2016, Journal of affective disorders.

[14]  I. Hickie,et al.  Clinical staging of major depressive disorder: an empirical exploration. , 2015, The Journal of clinical psychiatry.

[15]  Noortje Vriends,et al.  Social anxiety disorder, a lifelong disorder? A review of the spontaneous remission and its predictors , 2014, Acta psychiatrica Scandinavica.

[16]  Sandhya Ramrakha,et al.  The p Factor , 2014, Clinical psychological science : a journal of the Association for Psychological Science.

[17]  J. Nuyen,et al.  Stepped care for depression is easy to recommend, but harder to implement: results of an explorative study within primary care in the Netherlands , 2014, BMC Family Practice.

[18]  M. Olfson,et al.  Probability and predictors of first treatment contact for anxiety disorders in the United States: analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). , 2013, The Journal of clinical psychiatry.

[19]  R. de Graaf,et al.  Lifetime treatment contact and delay in treatment seeking after first onset of a mental disorder. , 2013, Psychiatric services.

[20]  J. Smit,et al.  Recurrence of anxiety disorders and its predictors. , 2013, Journal of affective disorders.

[21]  R. de Graaf,et al.  Common mental disorder severity and its association with treatment contact and treatment intensity for mental health problems , 2013, Psychological Medicine.

[22]  R. de Graaf,et al.  Recurrence of major depressive disorder and its predictors in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS) , 2012, Psychological Medicine.

[23]  P. Cuijpers,et al.  Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). , 2011, Journal of affective disorders.

[24]  R. de Graaf,et al.  The 7‐year course of depression and anxiety in the general population , 2011, Acta psychiatrica Scandinavica.

[25]  R. Graaf,et al.  The Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2): design and methods. , 2010 .

[26]  W. Katon,et al.  Clinical factors associated with relapse in primary care patients with chronic or recurrent depression. , 2007, Journal of affective disorders.

[27]  Fausto Mazzi,et al.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys , 2006, International journal of methods in psychiatric research.

[28]  I. Hickie,et al.  Clinical Staging of Psychiatric Disorders: A Heuristic Framework for Choosing Earlier, Safer and more Effective Interventions , 2006, The Australian and New Zealand journal of psychiatry.

[29]  M. Medina-Mora,et al.  Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey , 2005, Psychological Medicine.

[30]  M. Keller,et al.  Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. , 2005, The American journal of psychiatry.

[31]  R. Kessler,et al.  Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[32]  P. Roy-Byrne,et al.  Understanding and treating panic disorder in the primary care setting. , 2005, The Journal of clinical psychiatry.

[33]  R. Kessler,et al.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. , 2004, JAMA.

[34]  T. B. Üstün,et al.  The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) , 2004, International journal of methods in psychiatric research.

[35]  F. Smit,et al.  Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. , 2002, The American journal of psychiatry.

[36]  J Ormel,et al.  The structure and stability of common mental disorders: the NEMESIS study. , 2001, Archives of general psychiatry.

[37]  R. Krueger.  The structure of common mental disorders. , 1999, Archives of general psychiatry.

[38]  R. Kessler,et al.  Comorbidity of DSM–III–R Major Depressive Disorder in the General Population: Results from the US National Comorbidity Survey , 1996, British Journal of Psychiatry.

[39]  H. Kraemer,et al.  Comorbidity and Boundaries of Affective Disorders with Anxiety Disorders and Substance Misuse: Results of an International Task Force , 1996, British Journal of Psychiatry.

[40]  G. Fava,et al.  Staging: a neglected dimension in psychiatric classification , 1993, Acta psychiatrica Scandinavica.

[41]  T. Brugha,et al.  The List of Threatening Experiences: a subset of 12 life event categories with considerable long-term contextual threat , 1985, Psychological Medicine.